Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company's R&D Pipeline - Propanc Biopharma ( NASDAQ:PPCB )
MELBOURNE, Australia, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- Propanc Biopharma, Inc. ( NASDAQ:PPCB ) ( "Propanc" or the "Company" ) , a biopharmaceutical company developing new treatments for patients suffering from recurrent and metastatic cancer, today announced that it has entered into a ...